2018 Victoria Cruz and Rolf Brekken Victoria Cruz (Burton) Ph.D., Cancer BiologyThesis: Loss of TBK1 kinase function improves disease outcome in pancreatic cancer and metabolic syndrome 2016 Rolf Brekken and Mary Topalovski Mary Topalovski Ph.D., Cancer BiologyThesis: Fibulin-5 promotes pancreatic tumor growth through inhibition of integrin-induced ROSCurrently a postdoctoral fellow at UCSD. 2015 Rolf Brekken and Kristina Aguilera Kristina Aguilera Ph.D., Cancer BiologyThesis: Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-Mediated Tumorigenicity in Pancreatic Ductal AdenocarcinomaCurrently Scientist at BerGenBio, Bergen, Norway. 2011 Kristi Lynn, Rolf Brekken and Laura Sullivan Kristi Lynn Ph.D., Cancer BiologyThesis: Anti-VEGF Therapy Modulates Immune Cell Infiltration and Function in Multiple Breast Cancer ModelsCurrently a technology analyst at the Technology Transfer office at UT Southwestern. Laura Sullivan Ph.D., Cancer BiologyThesis: Anti-Angiogenic Therapy in Non-Small Cell Lung Cancer: Characterizing a New Therapy and Investigating Potential Mechanisms of ResistanceCurrently a consultant/analyst for ClearView Healthcare Partners, Newton, Mass. 2010 Rolf Brekken and Marie Schluterman Marie Schluterman Ph.D., Integrative BiologyThesis: Novel Function for Fibulin-5 in Controlling Integrin-Induced ROS Production: Implications on Angiogenesis and CancerCurrently a postdoctoral fellow at University of Arkansas for Medical Sciences, Little Rock, Ark. Lee Rivera Ph.D., Cell RegulationThesis: Regulation of Pericyte Behavior by Secreted Protein Acidic and Rich in CysteineCurrently a postdoctoral fellow at UC San Francisco. 2009 Shanna Arnold Ph.D., Integrative BiologyThesis: SPARC: a Matricellular Regulator of the Tumor Microenvironment Currently a postdoctoral fellow at Vanderbilt University.